Roles of lysophosphatidic acid in cardiovascular physiology and disease

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 9, 2008, Pages 563-570

  Smyth, Susan S ^a,b   Cheng, Hsin Yuan ^b   Miriyala, Sumitra ^b   Panchatcharam, Manikandan ^b   Morris, Andrew J ^b,c  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Lysophosphatidic acid Cardiovascular disease

Indexed keywords

LYSOPHOSPHATIDIC ACID;

ARTERY THROMBOSIS; BLOOD; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL FUNCTION; ENDOTHELIUM CELL; ENZYME SYNTHESIS; ENZYMOLOGY; HUMAN; IMMUNOCOMPETENT CELL; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE FUNCTION;

ANIMALS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; ENZYMES; HUMANS; LEUKOCYTES; LYSOPHOSPHOLIPIDS;

ANIMALIA;

EID: 49949110717     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.05.008     Document Type: Review

References (111)

1. Akbiyik F., Ray D.M., Gettings K.F., Blumberg N., Francis C.W., and Phipps R.P. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood 104 (2004) 1361-1368
2. Alexander J.S., Patton W.F., Christman B.W., Cuiper L.L., and Haselton F.R. Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro. Am. J. Physiol. 274 (1998) H115-H122
3. Amisten S., Braun O.O., Bengtsson A., and Erlinge D. Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb. Res. 122 (2007) 47-57
4. Aoki J. Mechanisms of lysophosphatidic acid production. Semin. Cell. Dev. Biol. 15 (2004) 477-489
5. Aoki J., Taira A., Takanezawa Y., Kishi Y., Hama K., Kishimoto T., Mizuno K., Saku K., Taguchi R., and Arai H. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J. Biol. Chem. 277 (2002) 48737-48744
6. Avraamides C., Bromberg M.E., Gaughan J.P., Thomas S.M., Tsygankov A.Y., and Panetti T.S. Hic-5 promotes endothelial cell migration to lysophosphatidic acid. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H193-H203
7. Baker D.L., Desiderio D.M., Miller D.D., Tolley B., and Tigyi G.J. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal. Biochem. 292 (2001) 287-295
8. Boguslawski G., Grogg J.R., Welch Z., Ciechanowicz S., Sliva D., Kovala A.T., McGlynn P., Brindley D.N., Rhoades R.A., and English D. Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response. Exp. Cell. Res. 274 (2002) 264-274
9. Boucharaba A., Serre C.M., Gres S., Saulnier-Blache J.S., Bordet J.C., Guglielmi J., Clezardin P., and Peyruchaud O. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J. Clin. Invest. 114 (2004) 1714-1725
10. Boucharaba A., Serre C.M., Guglielmi J., Bordet J.C., Clezardin P., and Peyruchaud O. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9643-9648
11. Brindley D.N. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J. Cell. Biochem. 92 (2004) 900-912
12. Chan L.C., Peters W., Xu Y., Chun J., Farese Jr. R.V., and Cases S. LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA). J. Leukoc. Biol. 82 (2007) 1193-1200
13. Chen Y.L., and Xu Y. Determination of lysophosphatidic acids by capillary electrophoresis with indirect ultraviolet detection. J. Chromatogr. B. Biomed. Sci. Appl. 753 (2001) 355-363
14. Chettibi S., Lawrence A.J., Stevenson R.D., and Young J.D. Effect of lysophosphatidic acid on motility, polarisation and metabolic burst of human neutrophils. FEMS Immunol. Med. Microbiol. 8 (1994) 271-281
15. Cho J., Degen J.L., Coller B.S., and Mosher D.F. Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain. J. Biol. Chem. 280 (2005) 35490-35498
16. Cho J., and Mosher D.F. Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood 108 (2006) 2229-2236
17. Cho J., and Mosher D.F. Role of fibronectin assembly in platelet thrombus formation. J. Thromb. Haemost. 4 (2006) 1461-1469
18. Cui M.Z., Laag E., Sun L., Tan M., Zhao G., and Xu X. Lysophosphatidic acid induces early growth response gene 1 expression in vascular smooth muscle cells: CRE and SRE mediate the transcription. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1029-1035
19. Cui M.Z., Zhao G., Winokur A.L., Laag E., Bydash J.R., Penn M.S., Chisolm G.M., and Xu X. Lysophosphatidic acid induction of tissue factor expression in aortic smooth muscle cells. Arterioscler Thromb. Vasc. Biol. 23 (2003) 224-230
20. Damirin A., Tomura H., Komachi M., Liu J.P., Mogi C., Tobo M., Wang J.Q., Kimura T., Kuwabara A., Yamazaki Y., Ohta H., Im D.S., Sato K., and Okajima F. Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H2513-H2522
21. Day S.M., Reeve J.L., Pedersen B., Farris D.M., Myers D.D., Im M., Wakefield T.W., Mackman N., and Fay W.P. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 105 (2005) 192-193
22. Eichholtz T., Jalink K., Fahrenfort I., and Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291 Pt 3 (1993) 677-680
23. English D., Kovala A.T., Welch Z., Harvey K.A., Siddiqui R.A., Brindley D.N., and Garcia J.G. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J. Hematother. Stem Cell Res. 8 (1999) 627-634
24. Eriksson A.C., Whiss P.A., and Nilsson U.K. Adhesion of human platelets to albumin is synergistically increased by lysophosphatidic acid and adrenaline in a donor-dependent fashion. Blood Coagul. Fibrinolysis 17 (2006) 359-368
25. Escalante-Alcalde D., Hernandez L., Le S.H., Maeda R., Lee H.S., Jr G.C., Sciorra V.A., Daar I., Spiegel S., Morris A.J., and Stewart C.L. The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development 130 (2003) 4623-4637
26. Federico L., Pamuklar Z., Liu S., Goto M., Dong A., Berdyshev E., Natarajan V., Fang F., Mills G.B., Morris A.J., and Smyth S.S. Overexpression of autotoxin/lysophospholipase D reveals a novel path for regulation of hemostasis in mice. Blood 110 (2007) 3649
27. Fourcade O., Simon M.F., Viode C., Rugani N., Leballe F., Ragab A., Fournie B., Sarda L., and Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80 (1995) 919-927
28. Gardell S.E., Dubin A.E., and Chun J. Emerging medicinal roles for lysophospholipid signaling. Trends Mol. Med. 12 (2006) 65-75
29. Gennero I., Xuereb J.M., Simon M.F., Girolami J.P., Bascands J.L., Chap H., Boneu B., and Sie P. Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture. Thromb. Res. 94 (1999) 317-326
30. Gerrard J.M., Kindom S.E., Peterson D.A., Peller J., Krantz K.E., and White J.G. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux. Am. J. Pathol. 96 (1979) 423-438
31. Gerrard J.M., and Robinson P. Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid. Biochim. Biophys. Acta 795 (1984) 487-492
32. Gerrard J.M., and Robinson P. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta 1001 (1989) 282-285
33. Goetzl E.J., and Rosen H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J. Clin. Invest. 114 (2004) 1531-1537
34. Gouni-Berthold I., and Sachinidis A. Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis. Curr. Vasc. Pharmacol. 2 (2004) 363-370
35. Gueguen G., Gaige B., Grevy J.M., Rogalle P., Bellan J., Wilson M., Klaebe A., Pont F., Simon M.F., and Chap H. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry 38 (1999) 8440-8450
36. Gustin C., Delaive E., Dieu M., Calay D., and Raes M. Upregulation of pentraxin-3 in human endothelial cells after lysophosphatidic acid exposure. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 491-497
37. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., Ohta H., Yamori T., Watanabe M., Chun J., and Arai H. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 279 (2004) 17634
38. Haseruck N., Erl W., Pandey D., Tigyi G., Ohlmann P., Ravanat C., Gachet C., and Siess W. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 103 (2004) 2585-2592
39. Hayashi K., Takahashi M., Nishida W., Yoshida K., Ohkawa Y., Kitabatake A., Aoki J., Arai H., and Sobue K. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 89 (2001) 251-258
40. Idzko M., Laut M., Panther E., Sorichter S., Durk T., Fluhr J.W., Herouy Y., Mockenhaupt M., Myrtek D., Elsner P., and Norgauer J. Lysophosphatidic acid induces chemotaxis, oxygen radical production, CD11b up-regulation, Ca2+ mobilization, and actin reorganization in human eosinophils via pertussis toxin-sensitive G proteins. J. Immunol. 172 (2004) 4480-4485
41. Itagaki K., Kannan K.B., and Hauser C.J. Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. J. Leukoc. Biol. 77 (2005) 181-189
42. Kanda H., Newton R., Klein R., Morita Y., Gunn M.D., and Rosen S.D. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 9 (2008) 415-423
43. Kawai-Kowase K., and Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J Physiol. Cell. Physiol. 292 (2007) C59-C69
44. Kishimoto T., Matsuoka T., Imamura S., and Mizuno K. A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. Clin. Chim. Acta 333 (2003) 59-67
45. Klages B., Brandt U., Simon M.I., Schultz G., and Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J. Cell. Biol. 144 (1999) 745-754
46. Korporaal S.J., Van E.M., Adelmeijer J., Ijsseldijk M., Out R., Lisman T., Lenting P.J., Van Berkel T.J., and Akkerman J.W. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2476-2483
47. Kou R., Igarashi J., and Michel T. Lysophosphatidic acid and receptor-mediated activation of endothelial nitric-oxide synthase. Biochemistry 41 (2002) 4982-4988
48. Lee H., Liao J.J., Graeler M., Huang M.C., and Goetzl E.J. Lysophospholipid regulation of mononuclear phagocytes. Biochim. Biophys. Acta 1582 (2002) 175-177
49. Lee S., and Lynch K.R. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA). Biochem. J. 391 (2005) 317-323
50. Lin C.I., Chen C.N., Chen J.H., and Lee H. Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. J. Cell. Biochem. 99 (2006) 1216-1232
51. Lin C.I., Chen C.N., Lin P.W., Chang K.J., Hsieh F.J., and Lee H. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3. Biochem. Biophys. Res. Commun. 363 (2007) 1001-1008
52. Llodra J., Angeli V., Liu J., Trogan E., Fisher E.A., and Randolph G.J. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U. S. A 101 (2004) 11779-11784
53. Maschberger P., Bauer M., Baumann-Siemons J., Zangl K.J., Negrescu E.V., Reininger A.J., and Siess W. Mildly oxidized low density lipoprotein rapidly stimulates via activation of the lysophosphatidic acid receptor Src family and Syk tyrosine kinases and Ca2+ influx in human platelets. J. Biol. Chem. 275 (2000) 19159-19166
54. McIntyre T.M., Pontsler A.V., Silva A.R., St H.A., Xu Y., Hinshaw J.C., Zimmerman G.A., Hama K., Aoki J., Arai H., and Prestwich G.D. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc. Natl. Acad. Sci. U. S. A 100 (2003) 131-136
55. Meerschaert K., De C., De V.V.Y., Vandekerckhove J., and Gettemans J. Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid. EMBO J. 17 (1998) 5923-5932
56. Meyer zu H.D., and Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta 1768 (2007) 923
57. Minnear F.L., Patil S., Bell D., Gainor J.P., and Morton C.A. Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L1337-L1344
58. Motohashi K., Shibata S., Ozaki Y., Yatomi Y., and Igarashi Y. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. FEBS Lett. 468 (2000) 189-193
59. Murph M., Tanaka T., Pang J., Felix E., Liu S., Trost R., Godwin A.K., Newman R., and Mills G. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. Methods Enzymol. 433 (2007) 1-25
60. Neidlinger N.A., Larkin S.K., Bhagat A., Victorino G.P., and Kuypers F.A. Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J. Biol. Chem. 281 (2006) 775-781
61. Nilsson U.K., Svensson S.P., and Grenegard M. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline. Haematologica 87 (2002) 730
62. Olorundare O.E., Peyruchaud O., Albrecht R.M., and Mosher D.F. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood 98 (2001) 117-124
63. Osborn T.M., Dahlgren C., Hartwig J.H., and Stossel T.P. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am. J. Physiol. Cell. Physiol. 292 (2007) C1323-C1330
64. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75 (1995) 487-517
65. Pamuklar Z., Lee J.S., Cheng H.Y., Panchatcharam M., Steinhubl S., Morris A.J., Charnigo R., and Smyth S.S. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler Thromb. Vasc. Biol. 28 (2008) 555-561
66. Pandey D., Goyal P., and Siess W. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation. Blood Cells Mol. Dis. 38 (2007) 269-279
67. Panetti T.S. Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. Biochim. Biophys. Acta 1582 (2002) 190-196
68. Panetti T.S., Nowlen J., and Mosher D.F. Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1013-1019
69. Panther E., Idzko M., Corinti S., Ferrari D., Herouy Y., Mockenhaupt M., Dichmann S., Gebicke-Haerter P., Di V.F., Girolomoni G., and Norgauer J. The influence of lysophosphatidic acid on the functions of human dendritic cells. J. Immunol. 169 (2002) 4129-4135
70. Pyne S., Long J.S., Ktistakis N.T., and Pyne N.J. Lipid phosphate phosphatases and lipid phosphate signaling. Biochem. Soc. Trans. 33 (2005) 1370-1374
71. Ray D.M., Spinelli S.L., O'Brien J.J., Blumberg N., and Phipps R.P. Platelets as a novel target for PPARgamma ligands: implications for inflammation, diabetes, and cardiovascular disease. BioDrugs. 20 (2006) 231-241
72. Ray D.M., Spinelli S.L., Pollock S.J., Murant T.I., O'Brien J.J., Blumberg N., Francis C.W., Taubman M.B., and Phipps R.P. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb. Haemost. 99 (2008) 86-95
73. Retzer M., and Essler M. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation. Cell Signal. 12 (2000) 645-648
74. Retzer M., Siess W., and Essler M. Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin. FEBS Lett. 466 (2000) 70-74
75. Rieken S., Herroeder S., Sassmann A., Wallenwein B., Moers A., Offermanns S., and Wettschureck N. Lysophospholipids control integrin-dependent adhesion in splenic B cells through G(i) and G(12)/G(13) family G-proteins but not through G(q)/G(11). J. Biol. Chem. 281 (2006) 36985-36992
76. Rizza C., Leitinger N., Yue J., Fischer D.J., Wang D.A., Shih P.T., Lee H., Tigyi G., and Berliner J.A. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab. Invest. 79 (1999) 1227-1235
77. Rother E., Brandl R., Baker D.L., Goyal P., Gebhard H., Tigyi G., and Siess W. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 108 (2003) 741-747
78. Saulnier-Blache J.S., Girard A., Simon M.F., Lafontan M., and Valet P. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J. Lipid Res. 41 (2000) 1947-1951
79. Schmitz U., Thommes K., Beier I., and Vetter H. Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 291 (2002) 687-691
80. Schumacher K.A., and Classen H.G. Platelet aggregation and increased pulmonary vascular resistance in cats induced by DAS and ADP. Naunyn Schmiedebergs Arch. Pharmacol. 275 (1972) 373-381
81. Schumacher K.A., Classen H.G., and Spath M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: identity with substances in aged serum (DAS). Thromb. Haemost. 42 (1979) 631-640
82. Sciorra V.A., and Morris A.J. Roles for lipid phosphate phosphatases in regulation of cellular signaling. Biochim. Biophys. Acta 1582 (2002) 45-51
83. Shan L., Jaffe K., Li S., and Davis L. Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 864 (2008) 22-28
84. Shen Z., Wu M., Elson P., Kennedy A.W., Belinson J., Casey G., and Xu Y. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases. Gynecol. Oncol. 83 (2001) 25-30
85. Siess W., and Tigyi G. Thrombogenic and atherogenic activities of lysophosphatidic acid. J. Cell Biochem. 92 (2004) 1086
86. Siess W., Zangl K.J., Essler M., Bauer M., Brandl R., Corrinth C., Bittman R., Tigyi G., and Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 6931-6936
87. Sigal Y.J., McDermott M.I., and Morris A.J. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem. J. 387 (2005) 281-293
88. Simon M.F., Chap H., and Douste-Blazy L. Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators?. Biochem. Biophys. Res. Commun. 108 (1982) 1743-1750
89. Smyth S.S., Sciorra V.A., Sigal Y.J., Pamuklar Z., Wang Z., Xu Y., Prestwich G.D., and Morris A.J. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity. J. Biol. Chem. 278 (2003) 43214-43223
90. Sutphen R., Xu Y., Wilbanks G.D., Fiorica J., Grendys Jr. E.C., LaPolla J.P., Arango H., Hoffman M.S., Martino M., Wakeley K., Griffin D., Blanco R.W., Cantor A.B., Xiao Y.J., and Krischer J.P. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1185-1191
91. Tager A.M., Lacamera P., Shea B.S., Campanella G.S., Selman M., Zhao Z., Polosukhin V., Wain J., Karimi-Shah B.A., Kim N.D., Hart W.K., Poorvu E.C., Brooks S.F., Bercury S.D., Pardo A., Blackwell T.S., Xu Y., Chun J., and Luster A.D. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Proc. Am. Thorac. Soc. 5 (2008) 363
92. Tanaka M., Okudaira S., Kishi Y., Ohkawa R., Iseki S., Ota M., Noji S., Yatomi Y., Aoki J., and Arai H. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J. Biol. Chem. 281 (2006) 25822-25830
93. Tigyi G., Hong L., Yakubu M., Parfenova H., Shibata M., and Leffler C.W. Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am. J. Physiol. 268 (1995) H2048-H2055
94. Tokumura A., Fukuzawa K., and Tsukatani H. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species. Lipids 13 (1978) 572-574
95. Tokumura A., Iimori M., Nishioka Y., Kitahara M., Sakashita M., and Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Physiol. 267 (1994) C204-C210
96. Tokumura A., Majima E., Kariya Y., Tominaga K., Kogure K., Yasuda K., and Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277 (2002) 39436-39442
97. Tokumura A., Sinomiya J., Kishimoto S., Tanaka T., Kogure K., Sugiura T., Satouchi K., Waku K., and Fukuzawa K. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem. J. 365 (2002) 617-628
98. Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T., Mills G.B., Inoue K., Aoki J., and Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158 (2002) 227-233
99. van Meeteren L.A., Frederiks F., Giepmans B.N., Pedrosa M.F., Billington S.J., Jost B.H., Tambourgi D.V., and Moolenaar W.H. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. J. Biol. Chem. 279 (2004) 10833-10836
100. van Meeteren L.A., and Moolenaar W.H. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 46 (2007) 145-160
101. van Meeteren L.A., Ruurs P., Stortelers C., Bouwman P., van Rooijen M.A., Pradere J.P., Pettit T.R., Wakelam M.J., Saulnier-Blache J.S., Mummery C.L., Moolenaar W.H., and Jonkers J. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 26 (2006) 5015-5022
102. van Nieuw Amerongen G.P., Vermeer M.A., and van H. V, Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler. Thromb. Vasc. Biol. 20 (2000) E127-E133
103. Wang L., Knudsen E., Jin Y., Gessani S., and Maghazachi A.A. Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells. Cell Signal. 16 (2004) 991-1000
104. Xiao Y.J., Schwartz B., Washington M., Kennedy A., Webster K., Belinson J., and Xu Y. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal. Biochem 290 (2001) 302-313
105. Xu Y., Shen Z., Wiper D.W., Wu M., Morton R.E., Elson P., Kennedy A.W., Belinson J., Markman M., and Casey G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280 (1998) 719-723
106. Xu Y.J., Aziz O.A., Bhugra P., Arneja A.S., Mendis M.R., and Dhalla N.S. Potential role of lysophosphatidic acid in hypertension and atherosclerosis. Can. J. Cardiol. 19 (2003) 1525-1536
107. Yoon H.R., Kim H., and Cho S.H. Quantitative analysis of acyl-lysophosphatidic acid in plasma using negative ionization tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci 788 (2003) 85-92
108. Yoshida K., Nishida W., Hayashi K., Ohkawa Y., Ogawa A., Aoki J., Arai H., and Sobue K. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 108 (2003) 1746-1752
109. Yue J., Yokoyama K., Balazs L., Baker D.L., Smalley D., Pilquil C., Brindley D.N., and Tigyi G. Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level. Cell Signal. 16 (2004) 385-399
110. Zhang C., Baker D.L., Yasuda S., Makarova N., Balazs L., Johnson L.R., Marathe G.K., McIntyre T.M., Xu Y., Prestwich G.D., Byun H.S., Bittman R., and Tigyi G. Lysophosphatidic acid induces neointima formation through PPARgamma activation. J. ExpMed. 199 (2004) 763-774
111. Zhang N., Sundberg J.P., and Gridley T. Mice mutant for Ppap2c, a homolog of the germ cell migration regulator wunen, are viable and fertile. Genesis. 27 (2000) 137-140